Genmab
Genmab creates and develops human antibody products for the treatment of life threatening and debilitating diseases.
Business Model:
Revenue: $2.4B
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Genmab Information
Geographic Data
Address: Kalvebod Brygge 43
City: Copenhagen
State: capital region
Zip: 1560
Country: DK
Financial Info
Stage:
post ipo equity
Raised Last:
$134M
Raised Total:$204M
Social
Metrics
954,595Website Global Rank
28,116Website Monthly Traffic
Twitter Followers
Description
Genmab creates and develops human antibody products for the treatment of life threatening and debilitating diseases.
Contact Phone:
Contact Email:
Genmab went public on 7/17/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/17/2019
IPO Valuation:
$1B
Ticker Symbol:
GMAB
IPO Price:
$17.75/share
Amount Raised:
$506M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2021 | Bolt Biotherapeutics | Post-IPO Equity | 15M |
| 6/2021 | Bolt Biotherapeutics | Post-IPO Equity | 0 |
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
